FDA Issues Warning Letter to Medinatura New Mexico
December 23, 2025
December 23, 2025
WASHINGTON, Dec. 23 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Medinatura New Mexico Inc. from the Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Clifford Clive, CEO, Medinatura New Mexico, Inc., 10421 Research Road SE, Albuquerque, NM 87123, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26 . . .
* * *
Recipient: Mr. Clifford Clive, CEO, Medinatura New Mexico, Inc., 10421 Research Road SE, Albuquerque, NM 87123, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26 . . .